Scevola Silvia, Youssef Adel, Kroll Stephen S, Langstein Howard
Department of Plastic Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030-4009, USA.
Ann Plast Surg. 2002 May;48(5):511-4. doi: 10.1097/00000637-200205000-00011.
Surgeons who perform transverse rectus abdominis musculocutaneous (TRAM) flaps have differing opinions about how many drains are required in the breast and abdomen to prevent seroma. The authors therefore decided to review their experience to determine whether the number of drains influenced the incidence of seroma. All patients who underwent breast reconstruction using TRAM or deep inferior epigastric perforator flaps at The University of Texas M. D. Anderson Cancer Center from January 1, 1995 to June 20, 2000 and whose charts could be retrieved were included in the study. The number of drains used was correlated with the presence or absence of seroma and wound infection in both the abdomen and the breast. Significance was analyzed using the Chi-squared and Fisher's exact tests. There were 608 patients and 768 reconstructive procedures in this series (160 reconstructions were bilateral). Of patients who had only one drain in the abdomen, seroma developed in 9 patients (7.1%), whereas of those having two drains in the abdomen, seroma developed in only 10 patients (2.1%) (p = 0.006). Also, of patients who had only one drain in the breast, seroma developed in the breast in 47 patients (9.1%), and in those with two drains, seroma developed in only 11 patients (4.3%) (p = 0.02). There were no significant differences in the infection rate in either the breast or the abdomen, although the trends favored a lower infection risk when two drains were used. The authors found that using two drains in both the abdomen and the breast can reduce the risk for seroma without increasing the risk for infection. This study supports the use of two drains in both the breast (one each beneath the TRAM flap and in the axilla) and abdomen (beneath the abdominoplasty flap) for patients undergoing breast reconstruction using the TRAM flap.
进行腹直肌肌皮瓣(TRAM)手术的外科医生对于乳房和腹部需要放置多少引流管以预防血清肿存在不同意见。因此,作者决定回顾他们的经验,以确定引流管的数量是否会影响血清肿的发生率。所有于1995年1月1日至2000年6月20日在德克萨斯大学MD安德森癌症中心接受TRAM或腹壁下深动脉穿支皮瓣乳房重建且病历可检索的患者均纳入本研究。所使用引流管的数量与腹部和乳房血清肿的有无以及伤口感染相关。采用卡方检验和费舍尔精确检验分析显著性。本系列中有608例患者和768例重建手术(160例为双侧重建)。腹部仅放置一根引流管的患者中,9例(7.1%)出现血清肿,而腹部放置两根引流管的患者中,仅10例(2.1%)出现血清肿(p = 0.006)。此外,乳房仅放置一根引流管的患者中,47例(9.1%)乳房出现血清肿,而放置两根引流管的患者中,仅11例(4.3%)出现血清肿(p = 0.02)。乳房或腹部的感染率无显著差异,尽管使用两根引流管时感染风险有降低趋势。作者发现,在腹部和乳房均使用两根引流管可降低血清肿风险而不增加感染风险。本研究支持对于接受TRAM皮瓣乳房重建的患者,在乳房(TRAM皮瓣下方和腋窝各一根)和腹部(腹壁成形皮瓣下方)均使用两根引流管。